Chiron Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Chiron Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.9M	Buy	206,970 +15,682	+8%	+$900K	10.7%	1
2026 Q1	$11.6M	Buy	+191,288	New	+$11.2M	11.89%	1
2025 Q3	$12.8M	Sell	283,373 -3,040	-1%	-$142K	10.94%	1
2025 Q2	$13.3M	Sell	286,413 -13,195	-4%	-$648K	11.54%	1
2025 Q1	$18.3M	Sell	299,608 -109,920	-27%	-$6.41M	16.61%	1
2024 Q4	$23.2M	Sell	409,528 -35,078	-8%	-$1.96M	21.86%	1
2024 Q3	$23M	Sell	444,606 -7,778	-2%	-$365K	20.36%	1
2024 Q2	$18.8M	Buy	452,384 +5,664	+1%	+$253K	17.94%	1
2024 Q1	$24.2M	Buy	446,720 +2,105	+0.5%	+$107K	22%	1
2023 Q4	$22.8M	Sell	444,615 -25,095	-5%	-$1.32M	19.85%	1
2023 Q3	$27.3M	Sell	469,710 -8,963	-2%	-$549K	23.45%	1
2023 Q2	$30.6M	Buy	478,673 +1,538	+0.3%	+$103K	24.24%	1
2023 Q1	$33.1M	Sell	477,135 -9,013	-2%	-$636K	22.99%	1
2022 Q4	$35M	Sell	486,148 -35,991	-7%	-$2.71M	24.33%	1
2022 Q3	$37.1M	Sell	522,139 -15,058	-3%	-$1.09M	24.94%	1
2022 Q2	$41.4M	Sell	537,197 -80,823	-13%	-$6.16M	26.09%	1
2022 Q1	$45.1M	Sell	618,020 -95,696	-13%	-$6.43M	28.45%	1
2021 Q4	$44.5M	Sell	713,716 -370	-0.1%	-$21.7K	32.12%	1
2021 Q3	$42.3M	Buy	714,086 +50,004	+8%	+$3.29M	30.82%	1
2021 Q2	$44.4M	Sell	664,082 -100,971	-13%	-$6.58M	36.97%	1
2021 Q1	$48.3M	Sell	765,053 -7,414	-1%	-$461K	40.99%	1
2020 Q4	$47.9M	Sell	772,467 -11,612	-1%	-$714K	39.45%	1
2020 Q3	$47.3M	Buy	+784,079	New	+$47.2M	38.07%	1

Other funds holding BMY

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

ORIO

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Chiron Capital Management's BMY Position: Q2 2026 in Review

Chiron Capital Management increased its Bristol-Myers Squibb (BMY) stake by 8.2% in Q2 2026, buying an estimated $900K and bringing the position to 206,970 shares worth $11.9M. The position accounts for 10.7% of the portfolio, ranked #1.

Chiron Capital Management first reported a position in BMY in Q3 2020 and has held it in 23 quarters since. The position peaked at $48.3M in Q1 2021. 565 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Chiron Capital Management held 206,970 shares of Bristol-Myers Squibb worth $11.9M as of Q2 2026.
Chiron Capital Management bought 15,682 Bristol-Myers Squibb shares in Q2 2026, an estimated $900K.
Bristol-Myers Squibb made up 10.7% of Chiron Capital Management's portfolio in Q2 2026, its #1 holding.
Chiron Capital Management first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 23 quarters since.
Chiron Capital Management's Bristol-Myers Squibb position peaked at $48.3M in Q1 2021.
565 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Chiron Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.